CCR8 and triple-negative breast carcinoma: Previous studies have shown that CCR8 plays a role in the immunosuppressive function of Tregs [19], and antagonism of CCR8 has been reported to inhibit tumor growth in a few cancer types, including triple-negative breast cancer and bladder cancer [20, 21].